Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The calcium channel protein alpha subunit (α1 subunit) is the pore-forming component of voltage-gated calcium channels (VGCCs). It is responsible for ion selectivity, voltage sensing, gating, and drug binding. There are ten known genes encoding different α1 subunits, classified based on their electrophysiological properties (L-, N-, P/Q-, R-, and T-types). Each subtype has distinct physiological roles. The functional VGCC complex includes α₁, β, and α₂δ subunits. The α₁ subunits are targeted by clinically important drugs like dihydropyridines and gabapentinoids. Mutations can cause neurological disorders.
Dihydropyridines block L-type calcium channels; Gabapentinoids bind to α₂δ subunits affecting VGCC function
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium Channel Protein Alpha Subunit (Cav α1 subunit).